Filing Flows › Traws Pharma (TRAW) › Recalls, complaints & regulation
Traws Pharma (TRAW): clinical trials
Traws Pharma (TRAW) beyond its filings: 4 active clinical trials.
Traws Pharma's latest quarter
Traws Pharma, Q2 2025: revenue $2.7M (48× year over year), operating margin -45.7%, net loss $915K, operating cash flow −$6.0M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does Traws Pharma have?
4 active studies on ClinicalTrials.gov, 0 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.